MX9706098A - Producto y metodo para prevenir infeccion por virus respiratorio. - Google Patents

Producto y metodo para prevenir infeccion por virus respiratorio.

Info

Publication number
MX9706098A
MX9706098A MX9706098A MX9706098A MX9706098A MX 9706098 A MX9706098 A MX 9706098A MX 9706098 A MX9706098 A MX 9706098A MX 9706098 A MX9706098 A MX 9706098A MX 9706098 A MX9706098 A MX 9706098A
Authority
MX
Mexico
Prior art keywords
product
virus infection
respiratory virus
preventing respiratory
virus
Prior art date
Application number
MX9706098A
Other languages
English (en)
Other versions
MXPA97006098A (es
Inventor
Milo Duane Hilty
Steven Neal Anderson
Joseph Paul Schaller
Jim-Zhou Liu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23526176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9706098(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX9706098A publication Critical patent/MX9706098A/es
Publication of MXPA97006098A publication Critical patent/MXPA97006098A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Water Treatments (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Water Treatment By Sorption (AREA)

Abstract

Un método para tratar neumonía u otra enfermedad respiratoria causada por virus sincitial respiratorio, adenovirus, virus de parainfluenza o virus de influenza administrado oralmente un líquido, preferiblemente una formula infantil, conteniendo un anticuerpo para neutralizar el virus.
MXPA/A/1997/006098A 1995-02-10 1997-08-08 Producto y metodo para prevenir infeccion viral respiratoria MXPA97006098A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08386576 1995-02-10
US08/386,576 US5922344A (en) 1995-02-10 1995-02-10 Product for prevention of respiratory virus infection and method of use
PCT/US1996/001790 WO1996031186A2 (en) 1995-02-10 1996-02-08 Product and method for preventing respiratory virus infection

Publications (2)

Publication Number Publication Date
MX9706098A true MX9706098A (es) 1997-10-31
MXPA97006098A MXPA97006098A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
JP2002517167A (ja) 2002-06-11
ATE222771T1 (de) 2002-09-15
DK0808173T3 (da) 2002-11-04
EP0808173A2 (en) 1997-11-26
US5922344A (en) 1999-07-13
ES2184853T3 (es) 2003-04-16
WO1996031186A2 (en) 1996-10-10
EP0808173B1 (en) 2002-08-28
WO1996031186A3 (en) 1996-11-14
DE69623261T2 (de) 2003-04-17
PT808173E (pt) 2003-01-31
AU4866696A (en) 1996-10-23
CA2212562A1 (en) 1996-10-10
DE69623261D1 (de) 2002-10-02

Similar Documents

Publication Publication Date Title
DE69818707D1 (de) Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa
BG101118A (en) Therapeutical compounds
NZ515392A (en) Respiratory syncytial virus replication inhibitors
BR9908488A (pt) Composição farmacêutica de topiramato
ATE427129T1 (de) Abgabevorrichtung fur arzneimittel
BR9814375A (pt) Inibição de raf cinase usando difenil uréias substituìdas simétricas e assimétricas
NO20073429L (no) Anvendelse av et antistoff mot interleukin-6-reseptor for fremstilling av et farmasoytisk preparat
IS2863B (is) Arípíprazóllausn til gjafar um munn
DE3781730D1 (de) 1-hydroxy-3-(n-methyl-n-propylamino)propan-1,1-diphosphonsaeure verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel.
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
HUP0002296A2 (hu) Sertralinsók és a sertralin elnyújtott felszabadulását biztosító dózisformák
MA22842A1 (fr) Procede de preparation de compositions de vaccin.
ATE192142T1 (de) Aminosäurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0652011A4 (en) PROPHYLACTIC AGENT AND CURATIVE AGENT AGAINST VIRAL DISEASES OF THE RESPIRATORY TRACT.
OA08652A (fr) Compositions, vaccin et anticorps monoclonaux utiles pour le traitement des affections par le virus HIV et procédés de production de ces anticorps et de diagnostic de la présence de ce virus.
MA24339A1 (fr) Procede de preparation de medicaments destines au traitement d'infections bacteriennes en pediaterie
DE69328635D1 (de) Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren
WO1996031186A3 (en) Product and method for preventing respiratory virus infection
NO982989L (no) Anvendelse av inhibitorer av den cellulµre Na+/H+-utbytteren (NHE) for fremstilling av et medikament for respiratorstimulering
NO975679L (no) Fremgangsmåte for fremstilling av N-monosubstituerte og N,N'-disubstituerte, usymmetriske, cykliske ureaer
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
FR2725990B1 (fr) Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
EE200200088A (et) Bis-sulfoonamiidide kasutamine ravimite valmistamiseks, mis on ette nähtud hüperlipideemia ärahoidmiseks või raviks
EE9600109A (et) a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid
BR0115611A (pt) Derivados de ciclohexano substituìdos e seu uso em medicamentos para tratamento de doenças cardiovasculares

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees